| Company Name |
Cohance Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202503 |
| Full Year |
| Equity (Rs.Cr.) |
38.26 |
| B.V. Rs. |
115.30 |
| Sales Rs. Cr. |
1,093.51 |
| NP Rs. Cr. |
271.77 |
| NP Var% |
-8.00 |
| Div% |
0.00 |
| CPS Rs. |
8.60 |
| EPS Rs. |
7.10 |
| Traded Value(Rs.Lakhs) |
186.53 |
| 52 Week High |
1,247.00 |
| 52 Week Low |
298.00 |
| Price BSE |
304.00 |
| Price NSE |
303.00 |
| Market Capital(Rs. Cr.) |
11,618.56 |
| P/C Ratio |
35.40 |
| P/E Ratio |
42.80 |
| Price Vs.BV |
2.64 |
| Year End |
202512 |
| Sales Rs. Cr. |
481.58 |
| NP Rs. Cr. |
50.80 |
| NP Var % |
-67.00 |
| Year End |
202512 |
| Sales |
914.50 |
| OPM |
38.71 |
| NP |
247.20 |
| NP Var% |
-19.81 |
| EPS |
8.84 |
| PE |
34.36 |
|
|